| Medical devices; 30-day notices and 135-day PMA (premarket approval application) supplement review; companion document to direct final rule--FDA. Proposed rule. | |
| | |
MedLine Citation:
|
PMID: 10179320 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The Food and Drug Administration (FDA) is proposing to amend its regulations governing the submission and review of premarket approval application (PMA) supplements to allow for the submission of a 30-day notice for modifications to manufacturing procedures or methods of manufacture. Amendments are being made to implement revisions to the Federal Food, Drug, and Cosmetic Act (the act) as amended by the Food and Drug Administration Modernization Act of 1997 (FDAMA). This proposed rule is a companion document to the direct final rule published elsewhere in this issue of the Federal Register. |
| | |
Authors:
|
- |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Federal register Volume: 63 ISSN: 0097-6326 ISO Abbreviation: Fed Regist Publication Date: 1998 Apr |
Date Detail:
|
Created Date: 1998-06-25 Completed Date: 1998-06-25 Revised Date: 2000-12-18 |
Medline Journal Info:
|
Nlm Unique ID: 7808722 Medline TA: Fed Regist Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 20558-61 Citation Subset: H |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Device Approval
/
legislation & jurisprudence* Equipment Safety Forms and Records Control / legislation & jurisprudence Industry / legislation & jurisprudence* Time Factors United States United States Food and Drug Administration |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Medical devices; 30-day notices and 135-day PMA (premarket approval application) supplement review--...
Next Document: Radiology devices; classifications for five medical image management devices--FDA. Final rule.